|
| |
| | | 58078 | | 20.12.2007 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Exelon Patch 5 | transdermales Pflaster | Transdermal patch (Rivastigmine 9 mg) | N06DA03 | CI | | 02 | Exelon Patch 10 | transdermales Pflaster | Transdermal patch (Rivastigmine 18 mg) | N06DA03 | CI | | 05 | Exelon Patch 15 | transdermales Pflaster | Transdermal patch (Rivastigmine 27 mg) | N06DA03 | CI |
|
|
|
